期刊文献+

单核细胞趋化蛋白-1、白细胞介素-17和白细胞介素-23在狼疮性肾炎患者中的变化及其意义 被引量:2

Changes and significance of monocyte chemoattractant protein-1,interleukin-17 and interleukin-23 in patients with lupus nephritis
原文传递
导出
摘要 目的探讨单核细胞趋化蛋白-1(MCP-1)、白细胞介素-17(IL-17)和白细胞介素-23(IL-23)在狼疮性肾炎(LN)患者中的表达及其意义。方法采用酶联免疫吸附试验(ELISA)检测受试者血清中的MCP-1、IL-17和IL-23浓度,并对各组结果进行比较分析。结果MCP-1、IL-17和IL-23在LN组血清中的浓度显著高于非LN组、非LN组血清中的浓度显著高于对照组(P<0.05);LN组患者治疗后MCP-1、IL-17和IL-23浓度显著降低(P<0.05);MCP-1、IL-17和IL-23联合检测,敏感度、阴性预测值和约登指数比单项检测均有提高。结论MCP-1、IL-17和IL-23在LN患者中呈高表达,其浓度的变化对LN的诊断和疗效观察有重要的临床价值。 Objective To investigate the expressions and significance of monocyte chemoattractant protein-1(MCP-1),interleukin-17(IL-17)and interleukin-23(IL-23)in patients with lupus nephritis(LN).Methods The serum concentrations of MCP-1,IL-17 and IL-23 in the subjects were detected by enzyme-linked immunosorbent assay(ELISA),and the results of each group were compared and analyzed.Results The serum concentrations of MCP-1,IL-17 and IL-23 in LN group were significantly higher than those in non-LN group and control group(P<0.05).The concentrations of MCP-1,IL-17 and IL-23 were significantly decreased in the LN group after treatment(P<0.05).The combined detection of MCP-1,IL-17 and IL-23 showed an increase in sensitivity,negative predictive value and Yoden index compared with single test.Conclusion The index of MCP-1,IL-17 and IL-23 are highly expressed in LN patients,and their concentration changes have important clinical value for the diagnosis and therapeutic observation of LN.
作者 金慧英 王恩智 曹景宏 周兴辉 唐玉霞 季伟星 JIN Hui-ying;WANG En-zhi;CAO Jing-hong;ZHOU Xing-hui;TANG Yu-xia;JI Wei-xing(Taizhou Hospital of Integrated Traditional Chinese and Western Medicine,Taizhou,Zhejiang 317523,China)
出处 《中国卫生检验杂志》 CAS 2020年第17期2109-2110,2113,共3页 Chinese Journal of Health Laboratory Technology
基金 温岭市科技局(2018C312029)。
关键词 单核细胞趋化蛋白-1 白细胞介素-17 白细胞介素-23 狼疮性肾炎 Monocyte chemoattractant protein-1 Interleukin-17 Interleukin-23 Lupus nephritis
  • 相关文献

参考文献3

二级参考文献28

  • 1Tian SY,Feldman BM,Beyene J,et al.Immunosuppressive therapies for the maintenance treatment of proliferative lupus nephritis:A systematic review and network metaanalysis[J].J Rheumatol,2015,42:1392-1400. 被引量:1
  • 2Zhang Z,Kyttaris VC,Tsokos GC.The role of IL-23IL-17 axis in lupus nephritis[J].J Immunol,2009,183:3160-3169. 被引量:1
  • 3Zickert A,Amoudruz P,Sundstrom Y,et al.IL-17and IL-23 in lupus nephritis-association to histopathology and response to treatment[J].BMC Immunol,2015,16:7. 被引量:1
  • 4Abdel Galil SM,Ezzeldin N,El-Boshy ME,et al.The role of serum IL-17 and IL-6 as biomarkers of disease activity and predictors of remission in patients with lupus nephritis[J].Cytokine,2015,76:280-287. 被引量:1
  • 5Korn T,Bettelli E,Oukka M,et al.IL-17 and Th17Cells[J].Annu Rev Immunol,2009,27:485-517. 被引量:1
  • 6Lubberts E.The IL-23-IL-17 axis in inflammatory arthritis[J].Nat Rev Rheumatol,2015,11:415-429. 被引量:1
  • 7Vincent FB,Northcott M,Hoi A,et al.Clinical associations of serum interleukin-17 in systemic lupus erythematosus[J].Arthritis Res Ther,2013,15:R97. 被引量:1
  • 8Chen DY,Chen YM,Wen MC,et al.The potential role of Th17 cells and Th17-related cytokines in the pathogenesis of lupus nephritis[J].Lupus,2012,21:1385-1396. 被引量:1
  • 9Teng MW,Bowman EP,Mc Elwee JJ,et al.IL-12and IL-23 cytokines:from discovery to targeted therapies for immune-mediated inflammatory diseases[J].Nat Med,2015,21:719-729. 被引量:1
  • 10Du J,Li Z,Shi J,et al.Associations between serum interleukin-23 levels and clinical characteristics in patients with systemic lupus erythematosus[J].J Int Med Res,2014,42:1123-1130. 被引量:1

共引文献21

同被引文献21

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部